Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-22-263616
Filing Date
2022-10-17
Accepted
2022-10-17 13:35:53
Documents
4
Period of Report
2022-10-17

Document Format Files

Seq Description Document Type Size
1 6-K d414881d6k.htm 6-K 9719
2 EX-99.1 d414881dex991.htm EX-99.1 36329
3 GRAPHIC g414881g0909193202133.jpg GRAPHIC 2601
4 GRAPHIC g414881g0909193203071.jpg GRAPHIC 1085
  Complete submission text file 0001193125-22-263616.txt   52580
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 221313367
SIC: 2834 Pharmaceutical Preparations